tRNAs from all organisms are extensively modified, with numerous alterations of base and ribose moieties at different positions (47) . In the yeast Saccharomyces cerevisiae, 25 different chemical modifications of tRNA have been described. These occur at 34 positions, and each tRNA bears ϳ11 modifications (22) . Although many of these modifications and the corresponding modification enzymes are highly conserved in different organisms, only three modification enzymes are known to be essential in yeast. Gcd10p/Gcd14p catalyzes formation of m 1 A 58 , which occurs in numerous tRNA species and is essential for tRNA i Met (3) . Tad2p/Tad3p catalyzes adenosine deaminase activity to form I 34 , which affects seven yeast tRNAs (13) . Thg1p catalyzes tRNA His guanylyltransferase activity to add an extra guanine nucleotide to the 5Ј end of tRNA His at position Ϫ1, called G Ϫ1 (17) . A unique feature of all tRNA His species is the presence of an extra G Ϫ1 residue opposite the discriminator base at position 73. Among more than 500 characterized tRNA species, only one other tRNA species, tRNA
Phe from Tetrahymena pyriformis mitochondria, has an additional residue at its 5Ј end (43) . The extra G Ϫ1 residue of tRNA His is generated in two very different ways. In prokaryotes, chloroplasts, and plant mitochondria, G Ϫ1 is genome encoded and retained in the mature tRNA His because RNase P cleaves at an unusual position to form an 8-bp aminoacyl stem containing G Ϫ1 -C 73 (7, 34) . By contrast, for eukaryotic cytoplasmic tRNA His and at least one animal mitochondrial tRNA His , G Ϫ1 is not genome encoded (27) but instead is added posttranscriptionally.
We demonstrated previously that the essential protein Thg1p has tRNA His guanylyltransferase activity in vitro and is required for G Ϫ1 addition to tRNA His in vivo (17) . We used a biochemical genomics screen (30) to show that glutathione S-transferase-Thg1p copurifies with yeast tRNA His guanylyltransferase activity and then showed that yeast Thg1p expressed and purified from Escherichia coli has the correct activity in vitro. This reaction is highly specific for tRNA His , and the 3Ј35Ј extension of a polynucleotide chain catalyzed by Thg1p is highly unusual. The only other similar 3Ј35Ј polynucleotide extension activity is that found in the mitochondria of the amoeboid protist Acanthamoeba castellani (36) and the chytridiomycete fungus Spizellomyces punctatus (6) , which are likely responsible for editing the 5Ј ends of tRNAs (28) . Thg1p adds G Ϫ1 to monophosphorylated tRNA His (p-tRNA His ) by a ligase-like mechanism, involving formation of an Ap-p-tRNA His -adenylylated intermediate, and removal of the AMP moiety during subsequent G Ϫ1 addition (17) ; however, Thg1p lacks any of the six characteristic motifs found in the superfamily of ligases/mRNA capping enzymes (45) . We also demonstrated that Thg1p is required for tRNA His guanylyltransferase in vivo, by showing that as cells are depleted of Thg1p they accumulate tRNA His lacking G Ϫ1 (17) . Here we investigate the cellular events that occur as cells stop growing when depleted of Thg1p, with the objective of explaining the essential function of Thg1p and of probing the physiological responses of loss of Thg1p and of G Ϫ1 from tRNA His . Four results are described. First, we show that the accumulation of tRNA His lacking G Ϫ1 is accompanied by coincident appearance of uncharged tRNA His , which may explain why Thg1p is essential. Second, we show that Thg1p-depleted cells appear to activate the GCN4 pathway, which normally responds to amino acid or purine starvation by increased expression of a number of genes involved in amino acid biosynthesis (21) . Third, we show by fluorescence in situ hybridization (FISH) that tRNA His accumulates in the nucleus in Thg1p-depleted cells. Fourth, we found unexpectedly that the tRNA His is, to our knowledge, the first example of additional tRNA modifications observed during a cellular response in eukaryotes, and its timing suggests that the accumulation of m 5 C is an indirect consequence of lack of Thg1p. The additional m 5 C might be caused by a prolonged presence of uncharged tRNA in the nucleus, or it might be part of a regulatory response.
MATERIALS AND METHODS
Yeast strains. Strains 13050 (trm4-⌬) and 13642 (gcn2-⌬) are derivatives of BY4742 and are from Research Genetics. Strains WG18 (thg1-⌬0:kanMX [CEN URA3 P GAL10 -THG1]) and WG12 (THG1 ϩ [CEN URA3 P GAL10 -THG1]) were described previously (17) . Strain BY4741 and the los1-⌬ derivative (YDO5055) are from Open Biosystems. Strain EE1b-6, harboring the thermosensitive Ran-GAP allele rna1-1, was previously described (52) . To construct a trm4-⌬ strain conditionally lacking Thg1p, we first switched the kanMX cassette in strain WG18 to natMX, essentially as described elsewhere (51) , to generate strain WG29 (relevant genotype, thg1-⌬0:natMX P GAL -THG1). Then, the trm4-⌬0: kanMX cassette and flanking sequence (Ϫ279 to ϩ297 relative to TRM4 ends) was PCR amplified from strain 13050 with primers (TRM4UP279, 5Ј-TAGCG AGAAGAAGTAGATGCATTTC; TRM4DN297, 5Ј-GATAAAAAATTCTCT GTCTCAATCCATG) and transformed into strain WG29 to generate WG30 (relevant genotype, thg1-⌬0::natMX P GAL -THG1 trm4-⌬0::kanMX). Strain WG32 (relevant genotype, thg1-⌬0::natMX P GAL -THG1 gcn2-⌬0::kanMX) was constructed in a similar way after PCR amplification of the gcn2-⌬0:kanMX cassette and flanking sequences (Ϫ241 to ϩ184 relative to the GCN2 ends) from strain 13642 with primers (GCN2UP241, 5Ј-GAGATAAGAACCTGGTGTAA TCAATC; GCN2DN184, 5Ј-GAAGTAGACCATCTCATTAAACCTAC). Control strains WG28 (trm4-⌬0::kanMX THG1 ϩ P GAL -THG1) and WG31 (gcn2-⌬0: kanMX THG1 ϩ P GAL -THG1) were constructed similarly. Strains were maintained on synthetic medium lacking uracil and then grown for analysis in YP medium (1% yeast extract, 2% peptone) containing 2% glucose (YPD) or 2% galactose (YPGal).
Preparation of RNA from yeast. Low-molecular-weight bulk RNA used for purification of individual tRNAs and for bisulfite sequencing was prepared as described Gu et al. (17) . Bulk RNA used for analysis of tRNA aminoacylation by Northern blotting was isolated under acidic conditions at 4°C as described previously (41) . Bulk RNA used for mRNA analysis by reverse transcriptase PCR (RT-PCR) or Northern blotting was isolated as described elsewhere (35) . Then, RNA was incubated with 40 U DNase I (Roche) in 150 l of buffer containing 10 mM Tris-Cl (pH 7.5) and 5 mM MgSO 4 at 25°C for ϳ30 min, followed by phenol extraction and ethanol precipitation. tRNA was deacylated by incubation in 100 l 0.1 M Tris-Cl (pH 9.0) for 30 min at 37°C, followed by precipitation and resuspension of RNA in 10 mM sodium acetate (pH 4.5) and 1 mM Na 2 -EDTA. tRNA His and tRNA Gly GCC were purified from low-molecular-weight RNA as described elsewhere (24) , with 5Ј-biotinylated oligomers (BioHis, 5Ј-/biotin/GC CATCTCCTAGAATCGAACC; BioGly, 5Ј-/biotin/TGGTGCGCAAGCCCGG AATCGAACC).
Analysis of tRNA. To analyze the 3Ј end of purified tRNA His , RNA was *pCp labeled and then sized by 4 M urea-10% polyacrylamide gel electrophoresis (PAGE), with a hydrolysis ladder as described elsewhere (26) or treated with 0.5 U/l RNase T 1 (Industrial Research, New Zealand) in buffer containing 50 mM Tris-Cl (pH 7.5), 2 mM EDTA, and 0.4 g/l bulk RNA at 37°C for 1 h, followed by 4 M urea-20% PAGE. Nucleosides were analyzed and quantified as described previously (12, 24) , using a C 18 high-performance liquid chromatography (HPLC) column. Northern blot assays of tRNA to detect aminoacylation were performed essentially as described elsewhere (41) . RNA was resolved on a 6.5% acid gel, electroblotted onto a Hybond N ϩ membrane (Amersham Biosciences), cross-linked by UV, and probed with the following specific primers: P1exP1 (5Ј-ACTAACCACTATACTAAGA) for tRNA Bisulfite mapping of m 5 C residues in tRNA. A 40% bisulfite solution was freshly prepared by dissolving 4.05 g of sodium bisulfite (Sigma) in 5.5 ml of water, adjusting the pH to 5.1 with 6.3 M sodium hydroxide, adding 33 l of 200 mM hydroquinone (Sigma), and adjusting the volume to 10 ml with water (15) . Sixty micrograms of bulk RNA was incubated in 75 l bisulfite solution for 30 min at 95°C and desalted by passage through a Micro Bio-spin 6 chromatography column (Bio-Rad). Then, RNA was desulfonated by incubation with 0.5 M Tris-Cl (pH 9.0) at 37°C for 1 h, followed by addition of a 1/10 volume of 10 M ammonium acetate and 20 g glycogen and precipitation with 2.5 volumes of ethanol. Remaining m 5 C residues in tRNA His were mapped by primer extension, using an appropriate primer modified for expected C-to-U changes from nucleotides (nt) 76 to 59 (tRNAHisform5C18nt, 5Ј-TAATACCATCTCCTAAAA), followed by 4 M urea-12.5% PAGE and PhosphorImager (Molecular Dynamics) visualization. Poison primer extensions contained ddGTP but no dGTP.
Analysis of mRNA. For RT-PCR, first-strand cDNA synthesis was performed with Moloney murine leukemia virus RT according to the manufacturer's instructions (Invitrogen). Then, RT was inactivated, and cDNA was diluted 16-fold in 10 mM Tris-Cl (pH 7.5) and amplified in 40-l mixtures containing 1 to 2 l of template cDNA, 3 mM MgCl 2 , 1ϫ PCR buffer (10 mM Tris-Cl, pH 8.3, 50 mM KCl), 0.25 mM deoxynucleoside triphosphate (dNTP), 1 l Taq polymerase, 0.5 M of each specific primer pair (in which either the forward or reverse primer was 32 P labeled), and a similarly labeled ACT1 primer pair as a control. PCR products were resolved on a 10% nondenaturing polyacrylamide gel. To confirm linearity of RT-PCR, a standard curve was generated using different amounts of RNA for first-strand synthesis. To quantify results, signals were first normalized to ACT1 and then normalized to the corresponding ratio in wild-type cells 6 h after glucose shift. Primers were the following: ACT1m (5Ј-TGGGTTTGGAA TCTGCCGGTATTG) and ACT13 (5Ј-TTAGAAACACTTGTGGTGAACGA TAG) for ACT1; LYS15m (5Ј-AGACACTACCAACCCTCACAACCC) and LYS13 (5Ј-CTATCGAACAATTTCTTGGCTCTAACC) for LYS1; ARG4m5 (5Ј-AAGATGGAAGCTGCTCTCACGATGG) and ARG4m3 (5Ј-AGCGGTT CCACCAGTAGCATCTCG) for ARG4; HIS5m (5Ј-GATCAACGGGGGTGA CAATGTCTTG) and HIS53 (5Ј-TTATTCATTGGCCAGCTTATATAACG) for HIS5; EFB15m (5Ј-TGGTTGCTAACGTCAAGGCCATCG) and EFB13 (5Ј-ATATCGGTAGATTGGACGTGGTCTTC) for EFB1. For Northern blot assays, ϳ20 g bulk RNA was resolved on a denaturing agarose gel, followed by transfer of RNA to a Hybond N ϩ membrane and hybridization to oligonucleotide probes (ACT13 for ACT1, LYS13 for LYS1, and ARG4m3 for ARG4).
FISH. FISH was performed as described previously (42), with modifications as described in reference 48, using previously described probes to tRNA A Nikon Microphot-FX microscope was used to observe fluorescence on the slides, and a Sensys charge-coupled device camera (Photometrics, Tucson, AZ) with QED software (QED Imaging, Pittsburgh) was used to capture the images. Adobe Photoshop 5.0 was used for image assembly.
RESULTS

Yeast cytoplasmic tRNA
His is not charged in Thg1p-depleted cells. Thg1p depletion might cause cell death because the accumulation of tRNA His lacking G Ϫ1 impairs aminoacylation, as has been shown in vitro (32, 40) , or because some other aspect of tRNA processing or function is affected. To address this question, we used a conditional mutant strain bearing a single THG1 gene under P GAL promoter control (relevant genotype, thg1-⌬ [CEN P GAL -THG1], referred to as thg1-⌬), and examined tRNA when cells were switched from permissive medium containing galactose (YPGal) to nonpermissive medium containing glucose (YPD), in which THG1 transcription is repressed. Cells begin to grow more slowly after 17 h in YPD medium and accumulate tRNA His lacking G Ϫ1 between 12 and 20 h after glucose shift, consistent with the loss of Thg1p activity in extracts (17) .
Thg1p-depleted cells accumulate uncharged tRNA His coordinately with the loss of G Ϫ1 . To analyze tRNA aminoacyla-tion, we isolated bulk RNA under acidic conditions, which stabilize the aminoacyl bond of tRNA, and compared RNA mobility on acidic polyacrylamide gels, before and after base treatment to remove the amino acid. Presence of the amino acid results in slower mobility of the tRNA. As shown in the Northern blot assay in Fig. 1 , aminoacylation of tRNA His in Thg1p-depleted cells is similar to that in control strains at early times (0 and 4.5 h) after glucose shift (lanes a to d and i to l) but is substantially reduced 16 h after the shift (lanes m and n) and almost completely absent 28 h after the shift (lanes o and p). Furthermore, tRNA
His levels are not substantially reduced during Thg1p depletion, relative to levels of the 5S RNA control. We note that the faster migration of tRNA His from Thg1p-depleted cells is not due to loss of G Ϫ1 , because transcripts of 76-mer tRNA His containing G Ϫ1 and 75-mer tRNA His lacking G Ϫ1 have similar mobilities in acidic gels (lanes q and r).
Loss of aminoacylation in Thg1p-depleted cells is specific for cytoplasmic tRNA
His . The aminoacylation status of cytoplasmic tRNA Lys , tRNA Tyr , tRNA Gly , and tRNA Arg does not change measurably during Thg1p depletion, although the observed basal aminoacylation levels differ for each species (Fig.  1) . Thus, loss of aminoacylation of tRNA His is not due to some general effect on aminoacylation caused by Thg1p depletion.
Loss of aminoacylation of cytoplasmic tRNA His is likely not due to loss of histidyl-tRNA synthetase (HisRS). We were able to probe HisRS activity in Thg1p-depleted cells, because yeast has only one gene encoding HisRS proteins for aminoacylation of both cytoplasmic tRNA His and mitochondrial tRNA His and because mitochondrial tRNA His has a genome-encoded G Ϫ1 that renders it insensitive to loss of Thg1p. Mitochondrial tRNA His is charged to the same extent both in control and in Thg1p-depleted cells (Fig. 1, lanes a to h and i to p) . Therefore, HisRS is fully active in mitochondria during Thg1p depletion, and we infer that HisRS is present and active in the rest of the cell.
tRNA His from Thg1p-depleted cells has a mature-size 3 end. One other possible explanation for the lack of aminoacylated tRNA His in Thg1p-depleted cells would be the lack of a mature CCA 3Ј end, since CCA is necessary for aminoacylation of tRNA. This could occur if G Ϫ1 were a determinant in vivo for CCA addition to tRNA His . To address this possibility, we purified cytoplasmic tRNA
His from Thg1p-depleted cells, after base treatment to deacylate any remaining aminoacylated tRNA, and examined its size after 3Ј-end labeling.
tRNA His from Thg1p-depleted cells has a 3Ј end of the same size as CCA-containing tRNA His from control cells (Fig. 2) . As expected, tRNA
His from control cells appears to have G Ϫ1 at its 5Ј end ( Fig. 2A, lanes b to e) , based on the hydrolysis ladder
His is not aminoacylated in Thg1p-depleted cells. Wild-type (WG12) and thg1 (WG18) strains were grown in YPGal medium and shifted to YPD medium to shut off Thg1p expression, and bulk RNA isolated was examined for tRNA aminoacylation status by base treatment to remove the amino acid, followed by gel electrophoresis and Northern analysis with specific probes, as described in Materials and Methods. His is the same length as in control cells ( Fig. 2A, lanes f and g) . However, at later times a substantial fraction of the tRNA His is 1 nucleotide shorter, about 60% after 16 h, and 85% after 28 h (Fig. 2A, lanes h and i) . Since we had previously shown by primer extension that this thg1-⌬ strain accumulates tRNA His lacking G Ϫ1 over the same time course (17), we conclude that tRNA His has lost G Ϫ1 and that the 3Ј end contains CCA.
To prove explicitly that tRNA His has a mature-size 3Ј end in Thg1p-depleted cells, we treated the tRNA with RNase T 1 to release the labeled 3Ј-terminal oligonucleotide after G 71 and compared its size to that from tRNA His of control cells. As shown in Fig. 2B , the 3Ј oligonucleotides of tRNA His from Thg1p-depleted and control cells are the same size after RNase T 1 treatment (lanes b to e and f to i) and the same size as the oligonucleotide from synthetic 75-mer tRNA His after similar treatment (lane j). This result provides compelling evidence that tRNA His in Thg1p-depleted cells contains a mature CCA end and that lack of aminoacylation is not due to a defect in its 3Ј-end maturation.
Comparison of the data in Fig. 1 and 2 also suggests that the amount of uncharged tRNA His corresponds closely to the amount of tRNA His lacking G Ϫ1 in Thg1p-depleted cells (see also below). His is altered in Thg1p-depleted cells, we purified tRNA His and quantified its nucleosides using HPLC.
We found unexpectedly that tRNA His from Thg1p-depleted cells has elevated levels of m 5 C. As shown in Fig. 3A , the modified nucleosides are resolved well enough to quantify them, except for rT, which is hidden by the G peak, and m 1 G/G m , which migrate together and can only be quantified as a group. Dihydrouridine is only observed at a different wave-
FIG. 2. tRNA
His in Thg1p-depleted cells is 1 nucleotide shorter but has an intact 3Ј end. Wild-type and thg1 (WG18) strains were grown as described in the legend for (Table 1) . By contrast, the peak corresponding to m 5 C is distinctly larger in Thg1p-depleted cells at late times after glucose shift (Fig. 3B) . This peak has the retention time and spectrum characteristic of m 5 C, suggesting that it represents additional m 5 C modification. Quantification reveals 1 mole of m 5 C in tRNA His from control cells (as expected) and from thg1-⌬ strains 4.5 h after glucose shift (Table 1) ; however, the amount of m 5 C increases to 1.3 mol 17 h after glucose shift and to 2.1 mol after 30 h ( Table 1 ). The increased m 5 C content is specific for tRNA His , because another purified tRNA (tRNA Gly ) shows no increased m 5 C content after Thg1p depletion ( Fig. 3D ; Table 1 ) and because m 5 C levels of bulk RNA do not change (data not shown).
Detailed examination of the timing of changes in tRNA His in Thg1p-depleted cells shows that loss of aminoacylation and G Ϫ1 appear coincidentally but the accumulation of additional m 5 C is delayed. Based on Fig. 1 and 2 (derived from one experiment) and Fig. 3 (derived from another experiment) , the m 5 C accumulation appears to be delayed, since after 16 to 17 h in YPD medium ϳ60% of tRNA His from Thg1p-depleted cells lacks G Ϫ1 (Fig. 2, lane h) and is not aminoacylated (Fig. 1, lane  m) , but m 5 C levels have only increased by ϳ30% (Table 1) . To examine the timing explicitly, we measured all three parameters from the same experiment (Fig. 4) . Our results show that loss of G Ϫ1 and aminoacylation occur with very similar time courses (as measured by the midpoint of the curves), whereas the accumulation of m 5 C in tRNA His is distinctly delayed, by as much as 8 h. Thus, m 5 C accumulation cannot be the cause of loss of aminoacylation of tRNA His and is instead a consequence of the loss of Thg1p.
Trm4p is responsible for the additional m 5 C modification. Since Trm4p is responsible for other known m 5 C modifications in yeast tRNA (31) , it seemed likely that Trm4p is also responsible for the additional m 5 C modification occurring during Thg1p depletion. Thus, we introduced a trm4 deletion into a thg1-⌬ strain and examined m 5 Wild-type and thg1 (WG18) strains were grown and harvested essentially as described in the legend for Fig. 1 , and tRNA was purified and nucleoside content was analyzed by HPLC. Peaks were identified based on spectra and retention time (12 50 . We developed a new method to map m 5 C modifications in tRNA, based on an m 5 C DNA mapping method (15) . When bisulfite-treated RNA is processed at a pH compatible with RNA, cytidine and derivatives (3-methylcytidine, 2Ј-O-methylcytidine, and N 4 -acetylcytidine) are quantitatively converted to uridine and the corresponding derivatives (data not shown). However, m 5 C is resistant to bisulfite treatment, suggesting that sites of m 5 C modification can be mapped by primer extension. One caveat in this analysis is the unexpected sensitivity of ⌿ to bisulfite treatment, which also causes a primer extension block (data not shown); however, as shown below, this does not affect mapping.
Primer extension shows that the new m 5 C modifications occur at C 48 Examination of individual species of tRNA His confirmed the location of the additional m 5 C residues and suggested that additional m 5 C modification occurs first at C 50 . To do this, we cloned cDNA from tRNA His by RT-PCR after bisulfite treatment to convert cytidine, but not m 5 C, to uridine and sequenced individual clones. Of 13 isolates examined, 6 had cytidine at position 49, 5 had cytidine at positions 49 and 50, and two had cytidine at positions 48, 49, and 50. This distribution demonstrates that all three cytidine residues can be modified in a given tRNA and suggests that modification at C 48 generally follows modification at position C 50 .
The GCN4 pathway is activated in Thg1p-depleted cells. Since Thg1p-depleted cells accumulate tRNA His lacking aminoacylation, it seemed likely that this uncharged tRNA His might activate the GCN4 pathway. In yeast, amino acid starvation or lack of functional tRNA synthetases derepresses translation of the transcription factor Gcn4p, which in turn activates transcription of a battery of genes encoding amino acid biosynthetic enzymes (19, 20) . Activation of Gcn4p is likely mediated by uncharged tRNAs, which activate the Gcn2p kinase to phosphorylate eIF2␣, leading ultimately to derepression of GCN4 translation (21) . Thus, although the uncharged tRNA His in Thg1p-depleted cells also lacks G Ϫ1 and contains an extra m 5 C at later times, it might also activate the GCN4 pathway.
Two lines of evidence suggest that Thg1p-depleted cells activate the GCN4 transcription control pathway. First, the mRNA levels of genes known to be induced by the GCN4 pathway are elevated in Thg1p-depleted cells, as shown by RT-PCR analysis (Fig. 6A ) and Northern analysis (Fig. 7) . RT-PCR analysis indicated that LYS1, HIS5, and ARG4 mRNA levels are each elevated between 19-fold and 35-fold relative to ACT1 mRNA levels in Thg1p-depleted cells (Fig.  6A ). For each of these genes, the increase in mRNA levels is to k) . Furthermore, each of two genes known not to be affected by the GCN4 pathway, EFB1 (encoding elongation factor B1) and ACT1, are not induced in Thg1p-depleted cells (Fig. 6B ). Northern analysis (Fig. 7) confirmed the induction of ARG4 and LYS1 in Thg1p-depleted cells. Second, activation of the GCN4 pathway in Thg1p-depleted cells is, as expected, mostly dependent on Gcn2p. To test the involvement of Gcn2p, we introduced a GCN2 deletion into the thg1-⌬ strain and measured mRNA levels of the same GCN4-regulated genes and negative controls. As shown in Fig.  6A , the dramatic increase in mRNA levels of HIS5, ARG4, or LYS1 observed in Thg1p-depleted cells was substantially reduced when Gcn2p was absent (lanes t to w); however, there was still a residual increase in mRNA levels (about two-to threefold, relative to ACT1 mRNA). As shown below, this residual increase in mRNA levels may be due to the presence of tRNA His in the nucleus, which can activate the GCN4 pathway independent of Gcn2p (37).
Thg1p depletion causes tRNA His to accumulate within the nucleus. In vertebrates and in yeast, inhibition of tRNA aminoacylation results in tRNA nuclear accumulation (14, 29, 41) . Since Thg1p depletion prevents aminoacylation of tRNA His by HisRS, we anticipated that such depletion would result in nuclear tRNA
His pools. To test this we employed FISH using an oligonucleotide complementary to tRNA His labeled at the 3Ј end with digoxigenin-11-dUTP and detected its location with fluoresceinated antidigoxigenin (42, 48) .
As anticipated, tRNA His is distributed throughout the cyto- plasm when a wild-type strain (BY4741) is grown in YPD medium (Fig. 8A , top row, left) and has an increased nuclear tRNA His signal in los1-⌬ cells, which lack the tRNA nuclear exportin (Fig. 8A, top row, right) . As shown in Fig. 8A (right, rows 3 and 4), thg1-⌬ cells (WG18) show prominent nuclear pools of tRNA His 14 h and 20 h after glucose shift, but not after 2 h (right, row 2), whereas control parent cells (WG12) have the same uniform distribution of tRNA His as the wild-type strain (Fig. 8A, left, rows 2 to 4) . This time course of appearance of nuclear tRNA His pools in thg1-⌬ cells mirrors the effect of Thg1p depletion upon loss of G Ϫ1 and loss of aminoacylation of tRNA His . Since depletion of Thg1p specifically affects aminoacylation of tRNA His (Fig. 1) , we evaluated the subcellular distributions of other tRNAs and mRNA to determine if the cellular distribution of tRNAs mirrors this cognate tRNA-specific effect. As anticipated, both tRNA Tyr and poly(A)-containing RNA are distributed throughout the nucleus and cytosol of wild-type cells (Fig. 8B , top row), but both accumulate in nuclei of rna1-1 cells (Fig. 8B, row 3 ), which have a defective RanGTP: RanGDP nucleus/cytoplasm gradient (11) . In contrast, and also as expected, los1-⌬ cells accumulate tRNA Tyr but not poly(A)-containing RNAs in the nucleus (Fig. 8B, row 2) . Neither control cells nor cells depleted of Thg1p for 14 h accumulate tRNA Tyr (Fig. 8B , rows 4 and 5), tRNA Met (data not shown), or poly(A)-containing RNAs in the nucleus (Fig.  8B, rows 4 and 5) . Thus, depletion of Thg1p appears to have a cognate-specific effect, causing specifically tRNA His to accumulate in the nucleus.
DISCUSSION
We have shown that a major consequence of depletion of Thg1p from yeast is the accumulation of uncharged tRNA (17) and loss of aminoacylation, we conclude that the likely cause of death of Thg1p-depleted cells is the lack of aminoacylated tRNA His . A recent study reports that Thg1p interacts with the origin recognition complex and suggests that Thg1p has a role in nuclear division and budding (39); it is not clear how this phenomenon is related to Thg1p G Ϫ1 addition activity.
The simplest interpretation of our observations is that lack of G Ϫ1 in tRNA His in Thg1p-depleted cells is the direct cause of lack of aminoacylation in vivo. This is consistent with previous studies showing that G Ϫ1 is a critical determinant for aminoacylation of tRNA His in vitro by yeast tRNA His synthetase (32, 40) , as is also true of E. coli tRNA His synthetase (18) . Since the loss of G Ϫ1 and aminoacylation in tRNA His also closely follows the loss of growth of Thg1p-depleted cells, it seems likely that lack of charged tRNA His is the limiting factor for cell growth. Uncharged tRNA His is unlikely to be caused by lack of active HisRS in the cell. HisRS is present and active in Thg1p-depleted cells, since mitochondrial tRNA His remains fully aminoacylated as Thg1p is depleted. Mitochondrial tRNA His has a genome-encoded G Ϫ1 residue that is, presumably, retained during tRNA maturation, as occurs in bacteria (8, 34) , obviating the need for Thg1p.
The accumulation of tRNA His in nuclei of thg1-⌬ cells is inferred to be caused by failure to aminoacylate this tRNA, because in yeast (42) and Xenopus laevis oocytes (29) disruption of tRNA synthetase function leads to nuclear accumulation of substrate tRNA. However, the mechanism for nuclear accumulation of tRNA His is not entirely clear. On one hand, lack of G Ϫ1 addition to nuclear tRNA His could prevent its aminoacylation in the nucleus and thereby inhibit its export to the cytosol, since Thg1p resides in the nucleus as well as in the cytoplasm (23) and it has been reported that there is histidyltRNA His in the nucleus (49) . This is consistent with our observation that some of the GCN4 pathway activation caused by lack of Thg1p is Gcn2p independent at a comparable time (18 h) (Fig. 6) , since it is known that there is a Gcn2-independent pathway for GCN4 activation that acts in the nucleus (37) . On the other hand, G Ϫ1 depletion could occur in the cytoplasm, leading to loss of aminoacylation and movement of tRNA from the cytosol to the nucleus (retrograde tRNA nuclear import), as has recently been reported (44, 50) .
It is interesting that the uncharged tRNA His that accumulates in the nucleus of Thg1p-depleted cells is apparently not subject to massive degradation. Recently, Anderson and coworkers (25) described a tRNA degradation pathway that acts in the nucleus to degrade pre-tRNA i Met lacking m 1 A 58 . We observe little obvious degradation of tRNA His in Thg1p-depleted cells (Fig. 1) , suggesting that, despite the absence of histidine charging and its presence in the nucleus, tRNA
His is not a substrate for large-scale degradation by this pathway. One possible reason might be that the tRNA His is in its native conformation and is therefore immune from this degradation system.
Since Gcn2p is located in the cytoplasm (23) and thought to function there (37) , the large component of GCN4 pathway activation that is Gcn2p dependent at 18 and 28 h (Fig. 6) suggests that a portion of uncharged tRNA His is located in the cytoplasm. This could occur because tRNA export is not absolutely dependent on tRNA charging (4, 29) , or because some population of cytoplasmic tRNA His loses its G Ϫ1 during growth in Thg1p-depleted cells, leading to a requirement for repair of the 5Ј end by Thg1p. The CCA-adding enzyme has such a repair role in yeast (53) . Regardless of the mechanism by which tRNA His ends up in the cytoplasm, we note that the amount of Gcn2p-dependent activation of the GCN4 pathway caused by tRNA His from Thg1p-depeleted cells is very similar to activation caused by other stimuli, such as 3-aminotriazole, that activate this pathway (33) . Since the GCN4 pathway is activated in response to 3-aminotriazole by binding of uncharged but otherwise mature tRNA His to Gcn2p to activate it to phosphorylate the alpha subunit of eIF2 (21), we conclude that uncharged tRNA His lacking G Ϫ1 can also serve the same role.
Surprisingly, we found that tRNA His accumulates additional m 5 C in Thg1-depleted cells, well after the loss of G Ϫ1 and aminoacylation. The extra m 5 C was mapped to C 50 (0.6 mol) and C 48 (0.4 mol) by development and use of a new RNA m 5 C mapping technique using bisulfite, adapted from a corresponding method for DNA (15) . These additional m 5 C sites in tRNA His flank the known modification site at C 49 , and C 50 is a new site for m 5 C modification of yeast tRNAs, although this site is modified in tRNA of some other organisms (47 (16, 38) , and other reports have suggested the possibility of lower modification levels in yeast tRNA under certain conditions (5, 46) , the accumulation of extra m 5 C in tRNA His of Thg1-depleted cells is, to our knowledge, the first documented case of additional tRNA modification appearing during a cellular response in eukaryotes. Recently, Björk and colleagues reported a gain-offunction mutation in Salmonella enterica that results in the synthesis of new tRNA modifications that affect tRNA function (10). The additional m 5 C modification described here might arise simply as a result of the prolonged presence of uncharged tRNA His in the nucleus, where Trm4p is known to be localized (54) . Alternatively, the additional m 5 C might arise as a response of some regulatory pathway that is initiated as a result of the accumulation of uncharged tRNA His . Consistent with the hypothesis of a regulatory role for tRNA modification, it was recently observed that human protein kinase B (Akt) and RSK can phosphorylate and inactivate Trm8p (9), one of two subunits required for m 7 G modification of tRNA (1, 2), suggesting that altered modification levels may occur during regulatory responses in the cell. It is somewhat of a puzzle why the m 5 C modification at C 48 and C 50 is incomplete. It is possible that Trm4p has difficulty modifying these sites. It is also possible that the incomplete modification of tRNA His reflects modification of the portion of cellular tRNA
His that is located in the nucleus, either the newly synthesized tRNA His or possibly cytoplasmic tRNA His that returns to the nucleus during Thg1p depletion (44, 50) . It is also somewhat of a mystery why the m 5 C modification is delayed relative to other consequences of loss of Thg1p. The delay could be directly related to the cause of inefficient modification, or it could be part of a regulatory response.
